Ferring Pharmaceuticals recently initiated a new research and development collaboration with Intralytix to develop a bacteriophage-based therapy for Inflammatory Bowel Disease (IBD). InflammatoryBowel Disease (IBD) is characterized by chronic inflammation in the digestive ... Read more